. Baseline characteristics by baseline heart failure status and digoxin use.
Heart failure (n=12124)
No heart failure (n=8981) [29] . º Percentages are for each region except for the Total column. † Ejection fraction was unknown for 5541 patients (heart failure-2682 patients; no heart failure-2859 patients). ‡ NYHA class at baseline was reported only in patients with HF. § Vitamin K antagonist experienced denotes ≥60 consecutive days of treatment with a vitamin K antagonist at any time prior to enrollment. 
